Glenn Dubin, the Highbridge Capital founder who called Jeffrey Epstein a friend and maintained financial ties to him for decades, has stepped down from the Mount Sinai board of trustees, where he served as vice-chair since 2007. His wife, Dr. Eva Andersson-Dubin — who dated Epstein before her marriage — simultaneously departed the board of Mount Sinai's Icahn School of Medicine. Mount Sinai says their terms ended in spring and they "did not seek re-election." The hospital declined to say whether its own Epstein-related review played any role. The Dubins are not the only Epstein-linked figures embedded in Mount Sinai's governance. Leon Black, the Apollo Global co-founder whom Congressman Thomas Massie named as one of 14 alleged "Epstein co-conspirators" on the House floor, served on Mount Sinai's board from 2001 to 2012 and the Icahn School of Medicine board through 2024. Black and his wife endowed a pediatrics chair in 2000 and established the hospital's stem cell institute in 2005. Congress voted unanimously last month to hold Black in contempt for refusing to comply with subpoenas demanding his deposition and all nondisclosure agreements. Attorney Brad Karp, former Paul Weiss chairman who resigned that position after Epstein-related emails surfaced, remains on Mount Sinai's board. The institutional entanglement runs deeper than board seats. According to DOJ files released in January, Epstein donated hundreds of thousands of dollars to Mount Sinai and its medical school after his 2008 conviction on state sex-trafficking charges. Those donations secured him "VIP" status at the hospital. In one documented incident, Dr. Jess Ting, a Mount Sinai surgeon, sewed 35 stitches into the forehead of a young Russian woman inside Epstein's Upper East Side townhouse dining room in October 2012, after she was injured on his Caribbean island. Four months later, Epstein directed a $50,000 check to Mount Sinai earmarked for Ting's research. Ting's 2017 breast cancer paper in Clinical Cancer Research acknowledged Epstein's funding. Ting received $4.6 million in compensation from Icahn School of Medicine in 2019. The Epstein files also reveal that Andersson-Dubin served as Epstein's "conduit" to Mount Sinai. In April 2012, she tried to arrange a volunteer position at the Dubin Breast Center for a young Russian woman at Epstein's request. When a hospital administrator objected on union grounds, Andersson-Dubin wrote to Epstein that the woman could "sit there and just look pretty," adding the administrator "has something against Russian girls I think." Epstein replied: "socialism." The volunteer position was ultimately approved after Andersson-Dubin appealed to the hospital. Mount Sinai's institutional response has been a study in managed opacity. In 2019, the hospital said it would donate "a sum equal to the donations we received from Mr. Epstein" to a human-trafficking charity, but has declined to say how much that was or to whom it went. The hospital reportedly formed a committee earlier this year to review its Epstein ties but has not responded to questions about whether that review concluded, what it found, or whether Ting faced any consequences. The New York state department of health acknowledged the allegations "clearly warrant review" but declined to discuss any active investigation. The architecture here is familiar: philanthropic donations convert into institutional access, board seats convert into reputational cover, and the institution's own governance structure makes accountability nearly impossible because the people who would order the investigation are the people under scrutiny. Massie's floor speech named names, but the DOJ has not acted. Mount Sinai's silence is not neutral — it is the sound of an institution protecting the structures that enriched it. The Dubins' spokesperson offered the standard formulation: had they known, they would have cut ties. But the Dubins continued socializing with Epstein in Palm Beach after his 2008 plea and conviction. The emails show Andersson-Dubin functioning as Epstein's institutional fixer at Mount Sinai as late as 2012. The question is not whether they knew about Epstein's crimes. The question is what the institution did with what it knew, and what the cost of answering that question honestly would be to everyone still on the board.
